Free Trial
NASDAQ:ELOX

Eloxx Pharmaceuticals (ELOX) Stock Price, News & Analysis

Eloxx Pharmaceuticals logo
$0.0001 0.00 (0.00%)
As of 08/4/2025 01:29 PM Eastern

About Eloxx Pharmaceuticals Stock (NASDAQ:ELOX)

Key Stats

Today's Range
$0.0001
$0.0001
50-Day Range
$0.00
$0.75
52-Week Range
$0.00
$0.75
Volume
219 shs
Average Volume
1,538 shs
Market Capitalization
$314.30
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ELOX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Eloxx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ELOX Stock News Headlines

He Called Nvidia at $1.10. Now, He Says THIS Stock Will…
The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvidia at $1.10 reveals AI’s Next Magnificent Seven… including one stock he says could become America’s next trillion-dollar giant.
Eloxx Pharmaceuticals Inc (ELOX)
See More Headlines

ELOX Stock Analysis - Frequently Asked Questions

Eloxx Pharmaceuticals' stock was trading at $0.0001 on January 1st, 2025. Since then, ELOX stock has increased by 0.0% and is now trading at $0.0001.

Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) issued its quarterly earnings data on Monday, April, 3rd. The company reported ($2.92) earnings per share for the quarter, topping analysts' consensus estimates of ($2.97) by $0.05.

Shares of ELOX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Eloxx Pharmaceuticals investors own include Tesla (TSLA), ADMA Biologics (ADMA), Adverum Biotechnologies (ADVM), Assertio (ASRT), Fulcrum Therapeutics (FULC), Acasti Pharma (ACST) and Akebia Therapeutics (AKBA).

Company Calendar

Last Earnings
4/03/2023
Today
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ELOX
CIK
1035354
Employees
30
Year Founded
2013

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
3,143,000
Free Float
2,508,000
Market Cap
$314.30
Optionable
Not Optionable
Beta
-1,550.12

Social Links

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:ELOX) was last updated on 8/7/2025 by MarketBeat.com Staff
From Our Partners